The influence of number of high risk factors on clinical outcomes in patients with early-stage cervical cancer after radical hysterectomy and adjuvant chemoradiation
- Authors
- 임소이; 이석호; 이광범; 박찬용
- Issue Date
- May-2016
- Publisher
- 대한산부인과학회
- Keywords
- Chemoradiation; High-risk factor; Prognosis; Radical hysterectomy; Uterine cervical neoplasms
- Citation
- Obstetrics & Gynecology Science, v.59, no.3, pp.184 - 191
- Journal Title
- Obstetrics & Gynecology Science
- Volume
- 59
- Number
- 3
- Start Page
- 184
- End Page
- 191
- URI
- https://scholarworks.bwise.kr/gachon/handle/2020.sw.gachon/9443
- DOI
- 10.5468/ogs.2016.59.3.184
- ISSN
- 2287-8572
- Abstract
- ObjectiveThe purpose of this study was to evaluate the prognosis according to the number of high risk factors in patients with high risk factors after radical hysterectomy and adjuvant chemoradiation therapy for early stage cervical cancer.
MethodsClinicopathological variables and clinical outcomes of patients with FIGO (International Federation of Gynecology and Obstetrics) stage IB1 to IIA cervical cancer who had one or more high risk factors after radical hysterectomy and adjuvant chemoradiation therapy were retrospectively analyzed. Patients were divided into two groups according to the number of high risk factors (group 1, single high risk factor; group 2, two or more high risk factors).
ResultsA total of 93 patients were enrolled in the present study. Forty nine out of 93 (52.7%) patients had a single high risk factor, and 44 (47.3%) had two or more high risk factors. Statistically significant differences in stage and stromal invasion were observed between group 1 and group 2. However, age, histology, tumor size, and lymphovascular space invasion did not differ significantly between the groups. Distant recurrence occurred more frequently in group 2, and the probability of recurrence and death was higher in group 2.
ConclusionPatients with two or more high risk factors had worse prognosis in early stage cervical cancer. For these patients, consideration of new strategies to improve survival may be worthwhile. Conduct of further clinical trials is warranted for development of adjuvant treatment strategies individualized to each risk group.
- Files in This Item
- There are no files associated with this item.
- Appears in
Collections - 의과대학 > 의학과 > 1. Journal Articles
![qrcode](https://api.qrserver.com/v1/create-qr-code/?size=55x55&data=https://scholarworks.bwise.kr/gachon/handle/2020.sw.gachon/9443)
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.